Category: Prescription Drugs

Categories
Medicare Policy & Trends Prescription Drugs resources-finance

Medicare Drug Price Negotiations: 15 More Drugs Targeted for 2027 Savings

On the heels of the first successful round of negotiated prices, Medicare has selected 15 additional high-cost drugs for price negotiations, with savings expected in 2027.

The list includes treatments for Type 2 diabetes, HIV, psoriasis, and severe arthritis. Negotiated prices could reduce out-of-pocket costs for millions of seniors who depend on these brand-name medications.

While the actual discounts won’t kick in until next year, beneficiaries should review their plan’s formulary notices this fall to anticipate changes.

Read the Reuters coverage on Investing.com

Categories
Medicare Part D Prescription Drugs resources-finance

How Medicare’s $2,000 Part D Out-of-Pocket Cap Is Saving Seniors Money

The new $2,000 annual out-of-pocket cap on Medicare Part D drug costs is already making a difference for seniors taking expensive prescriptions.

Since January 2026, once your covered out-of-pocket drug costs reach $2,000, your plan pays 100% of the cost for the rest of the year. This includes deductibles, copays, and coinsurance for brand-name and generic drugs on your plan’s formulary.

Additionally, the Medicare Prescription Payment Plan allows you to spread your costs across the calendar year instead of paying large sums all at once. This helps smooth out budgeting, especially for those who hit the cap early.

If you haven’t reviewed your Part D plan recently, now is a good time to see how the cap and payment plan could reduce your expenses, especially before the open enrollment season this fall.

Learn more at Medicare.gov

Categories
Medicare Benefits & Services Medicare Policy & Trends Prescription Drugs

Medicare GLP-1 Bridge Program Launches: $50 Weight-Loss Drugs Now Available

appy cheerful black senior plus size female with short haircut and eyeglasses having coffee break holding white cup while talking on phone with her friend, joking discussing funny situation

The new Medicare GLP-1 Bridge Program went live on July 1, 2026, giving eligible Part D enrollees access to certain weight-loss medications for a flat $50 monthly copay.

Covered drugs include Wegovy (injections and tablets), Zepbound (KwikPen only), and all formulations of Foundayo. Beneficiaries must have a BMI of 35+ or a BMI over 30 with weight-related comorbidities, and their doctor must submit a prior authorization form to CMS.

The copay does not count toward the Part D deductible or out-of-pocket maximum, but it offers significant savings for those who qualify. The demonstration runs through December 31, 2027.

Learn more at CMS.gov

Categories
Medicare Part D Prescription Drugs resources-finance

3 Big Medicare Prescription Drug Changes Affecting Seniors in 2026

AARP highlights three major shifts in Medicare Part D for 2026 that will directly impact seniors’ wallets. Foremost is the implementation of lower negotiated prices for 10 high-cost drugs—including Eliquis, Jardiance, and Entresto—which are expected to save enrollees an estimated $1.5 billion collectively.

Additionally, the Part D annual out-of-pocket spending cap has been adjusted to $2,100 for 2026 (up slightly from the initial $2,000 cap introduced in 2025). This indexing reflects standard programmatic adjustments but continues to protect seniors from catastrophic pharmacy bills.

Finally, the maximum Part D deductible has increased to $615 for the year. Beneficiaries are encouraged to use the Medicare Prescription Payment Plan to smooth out these costs over 12 months rather than paying large sums early in the year.

Read the complete breakdown at AARP

Categories
Medicare Part D news Prescription Drugs

Medicare Part D Now Covers Weight-Loss Drugs Like Wegovy and Zepbound

Medicare Part D plans can now cover weight-loss medications including Wegovy and Zepbound for beneficiaries with obesity, marking a significant expansion of prescription drug benefits.

The change reflects growing recognition of obesity as a chronic disease rather than a lifestyle condition, aligning Medicare coverage with newer medical guidelines.

Not all Part D plans include these medications on their formularies, so beneficiaries should check their plan’s covered drug list during enrollment periods.

Out-of-pocket costs vary by plan and may be affected by the Part D deductible and coverage gap phase. Beneficiaries taking these medications should review their plan annually.

Read the full coverage details at Medical News Today.

Categories
Medicare Part D Prescription Drugs

Weight-Loss Drug Coverage Creates New Medicare Tensions

Some Medicare drug plans may exceed proposed $50 monthly caps for weight-loss medications, raising questions about coverage limits and patient access. (Source: Reuters)

Key Takeaways

  • $50 monthly cap not guaranteed across all plans
  • Coverage varies significantly by insurer
  • Review your Part D formulary carefully

Source: Reuters